mobile-logo
 

All News

22 Apr

PAGE Meeting 2013

by 16by9
in Other News
Comments

  Dr Frances Brightman, Dr Christophe Chassagnole and Dr Eric Fernandez have been both accepted to present at this years PAGE Meeting in Glasgow. They will show an update, respectively on the cardiac toxicity platform, on the clinical virtual tumour research program and on drugCARD the anti-cancer drug combination database. Please click here for more information on the conference. ...

Read More
08 Apr

Physiomics to present new developments of the Virtual Tumour platform and the drugCARD Database at Annual Meeting for American Association for Cancer Research (“AACR”)

by 16by9
in Investor News / RNS
Comments

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it is participating in the AACR Annual Meeting 2013, taking place at the Walter E. Washington Convention Center, Washington, DC on 6-10 April 2013.  Dr Frances Brightman and Dr Eric Fernandez will present respectively on the application of the Virtual Tumour platform to radiotherapy prediction and on the latest...

Read More
25 Mar

Physiomics to provide cardiac toxicity modelling service

by 16by9
in Investor News / RNS
Comments

Physiomics plc (AIM: PYC), the Oxford, UK-based systems biology company, is pleased to announce the launch of its new cardiac toxicity modelling service. This new model predicts the risk of a fatal heart arrhythmia known as Torsade de Pointes, using low cost and relatively easy to obtain lab-based data. From 1990 to 2010, a dozen compounds were withdrawn from the market because of association with...

Read More
21 Mar

Workshop Invitation – Half-day workshop on 11th June 2013 at University of Strathclyde (Glasgow)

by 16by9
in Other News
Comments

Physiomics will present a half-day workshop on “The Prediction of Cardiotoxicity Using In Silico Tools”, ahead of the 2013 PAGE meeting. The workshop will start with a review and demonstration of the models currently available for analysing cardiac toxicity, from effects on individual myocyte action potentials to Torsade de Pointes risk categorisation. This general introduction will be followed by the presentation of Physiomics’ own cardiotoxicity prediction...

Read More
15 Mar

Systems Biology Symposium

by 16by9
in Other News
Comments

We are pleased to announce that Dr Hitesh Mistry will be the "Guest Speaker" of the Second Systems Biology Symposium at the Institute of Medical Sciences University of Aberdeen (March, 29, 2013). Hitesh will give a presentation entitled "Models for Drugs!". Please click here for more information on the conference. ...

Read More
15 Mar

1st Coordinating Action Systems Medicine (CASyM) stakeholder conference

by 16by9
in Other News
Comments

We are pleased to announce that Dr Christophe Chassagnole has been invited to contribute to the panel discussions of leading experts at the 1st CASyM stakeholders conference during Bio-Vision, the world life sciences forum in Lyon (March, 24-26, 2013).  CASyM is a European project, supported by the FP7- Directorate-General for Research and Innovation of the European Commission, to develop a road map outlining an integrative...

Read More
25 Feb

Physiomics to present at AACR Annual Meeting 2013

by 16by9
in Other News
Comments

Dr Frances Brightman and Dr Eric Fernandez have been accepted to present their posters at the AACR Annual Meeting 2013, which will take place April 6-10 in Washington, DC. The posters entitled “drugCARD: a database of anticancer treatment regimens and drug combinations” (#5147) and “Modeling ionizing radiation exposure in vitro and in vivo using the Virtual Tumour” (#5233) will present the latest technology advances developed...

Read More